Ligand validation:7MOS

ZLV: (3S,18S,20aR)-18-(6,6-dihydroxyoctyl)-1,5,6,7,8,18,19,20a-octahydro-4H-14,17-epiminoazeto[1,2-g][1,7,10,13]benzoxatriazacycloheptadecin-20(2H)-one

ZLV is a Ligand Of Interest in 7MOS designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7MOS_ZLV_A_412	63%	63%	0.124	0.92	0.64	0.77	1	1	0	0	100%	1
7MOS_ZLV_C_410	50%	75%	0.133	0.883	0.56	0.43	1	-	0	0	100%	1
7MOS_ZLV_B_410	50%	70%	0.142	0.89	0.6	0.54	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.